VCAN and non-small cell lung carcinoma: Compared with low plasma versican, the risk of NSCLC with high plasma versican was 7.222 (95%CI 3.102–16.812, P < 0.001) and the adjusted OR was 9.301 (95%CI 1.848–46.808, P = 0.007).